Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
出版年份 2021 全文链接
标题
Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-22
DOI
10.1186/s12933-021-01372-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study
- (2021) Agata Hanna Bryk et al. Cardiovascular Diabetology
- PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes
- (2021) Alessandra Giannella et al. Cardiovascular Diabetology
- Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
- (2021) Jonathan J. H. Bray et al. DIABETES OBESITY & METABOLISM
- PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
- (2021) Rawan Altalhi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of empagliflozin on erythropoiesis in patients with type 2 diabetes: Data from a randomized, placebo‐controlled study
- (2021) Kirsten Thiele et al. DIABETES OBESITY & METABOLISM
- Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes
- (2020) Marco Witkowski et al. Cardiovascular Diabetology
- Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective
- (2020) Bianca Rocca et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
- (2020) Wael Sumaya et al. THROMBOSIS AND HAEMOSTASIS
- The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial
- (2020) Deepak L. Bhatt et al. CIRCULATION
- Interaction of glycated and acetylated human α2-antiplasmin with fibrin clots
- (2020) Agata H. Bryk et al. BLOOD COAGULATION & FIBRINOLYSIS
- Empagliflozin decreases the plasma concentration of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with improvement of fibrinolysis
- (2020) Shintaro Sakurai et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes
- (2020) Marco Witkowski et al. CARDIOVASCULAR DRUGS AND THERAPY
- Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid
- (2020) Agata Hanna Bryk et al. THROMBOSIS RESEARCH
- Plasma Protein Oxidation as a Determinant of Impaired Fibrinolysis in Type 2 Diabetes
- (2019) Agata Bryk et al. THROMBOSIS AND HAEMOSTASIS
- Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis
- (2019) Safi U Khan et al. European Journal of Preventive Cardiology
- Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study
- (2019) Lisha Zhang et al. Cardiovascular Diabetology
- Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
- (2019) Agata H. Bryk et al. Cardiovascular Diabetology
- Ozone-induced damage of fibrinogen molecules: identification of oxidation sites by high-resolution mass spectrometry
- (2019) Lyubov Yurina et al. FREE RADICAL RESEARCH
- Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
- (2019) Nikolaos Spinthakis et al. EUROPACE
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?
- (2019) Cesar A. Meza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study
- (2019) Felix Aberer et al. DIABETES OBESITY & METABOLISM
- Identification of glycated and acetylated lysine residues in human α2-antiplasmin
- (2019) Agata Hanna Bryk et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Coagulatory Defects in Type-1 and Type-2 Diabetes
- (2019) Amélie I. S. Sobczak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetes
- (2019) Agata Hanna Bryk et al. THROMBOSIS RESEARCH
- The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo
- (2018) Lisa Menegazzo et al. ACTA DIABETOLOGICA
- MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes
- (2018) Marco Witkowski et al. Cardiovascular Diabetology
- Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017
- (2018) Thomas R. Einarson et al. Cardiovascular Diabetology
- Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
- (2018) Wael Sumaya et al. EUROPEAN HEART JOURNAL
- Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry
- (2018) Laurent Bertoletti et al. THROMBOSIS AND HAEMOSTASIS
- The level of circulating fibroblast activation protein correlates with incorporation of alpha-2-antiplasmin into the fibrin clot
- (2018) Shirley Uitte de Willige et al. THROMBOSIS RESEARCH
- Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis
- (2018) S McGurnaghan et al. DIABETIC MEDICINE
- Platelet activity and hypercoagulation in type 2 diabetes
- (2018) Lesha Pretorius et al. Cardiovascular Diabetology
- Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation
- (2018) Grzegorz Gajos et al. Cardiovascular Diabetology
- Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
- (2018) Paola Simeone et al. Nutrients
- Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban
- (2017) Agnieszka Janion-Sadowska et al. THROMBOSIS AND HAEMOSTASIS
- BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes
- (2017) Katie A. Greenhalgh et al. THROMBOSIS AND HAEMOSTASIS
- Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis
- (2017) Haozhe Qi et al. Frontiers in Immunology
- Fibrin Fiber Stiffness Is Strongly Affected by Fiber Diameter, but Not by Fibrinogen Glycation
- (2016) Wei Li et al. BIOPHYSICAL JOURNAL
- Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes
- (2016) Nino G. Joy et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release
- (2016) Guang Xin et al. Scientific Reports
- Effect of Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin on Plasminogen Activator Inhibitor-1 in Patients With Diabetes Mellitus
- (2015) Shigemasa Tani et al. AMERICAN JOURNAL OF CARDIOLOGY
- Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk
- (2015) Grzegorz Gajos et al. Cardiovascular Diabetology
- Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus
- (2015) Prashilla Soma et al. Cardiovascular Diabetology
- Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus
- (2015) Francesca Santilli et al. FREE RADICAL BIOLOGY AND MEDICINE
- Basic mechanisms and regulation of fibrinolysis
- (2015) C. Longstaff et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Epidemiology of venous thromboembolism
- (2015) John A. Heit Nature Reviews Cardiology
- Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots
- (2015) Laily D. Zubairova et al. Scientific Reports
- Increased Oxidation as an Additional Mechanism Underlying Reduced Clot Permeability and Impaired Fibrinolysis in Type 2 Diabetes
- (2015) Anna Lados-Krupa et al. Journal of Diabetes Research
- NETosis is induced by high glucose and associated with type 2 diabetes
- (2014) Lisa Menegazzo et al. ACTA DIABETOLOGICA
- Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment
- (2014) Thomas Forst et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3
- (2014) Katharina Hess et al. DIABETOLOGIA
- Effect of Metformin on Methylglyoxal Metabolism in Patients with Type 2 Diabetes
- (2014) Z. Kender et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications
- (2014) Hyun Kyung Kim et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid
- (2014) A. Undas et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease
- (2014) Søs Neergaard-Petersen et al. THROMBOSIS AND HAEMOSTASIS
- Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity
- (2013) R. A. Ajjan et al. BLOOD
- Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin
- (2013) D. B. Cines et al. BLOOD
- Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
- (2013) Yuji Ishibashi et al. Cardiovascular Diabetology
- Iron-Induced Fibrin in Cardiovascular Disease
- (2013) Boguslaw Lipinski et al. CURRENT NEUROVASCULAR RESEARCH
- Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study
- (2013) G. Lowe et al. DIABETES
- High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation
- (2013) Manjunath B. Joshi et al. FEBS LETTERS
- Mechanical Stability and Fibrinolytic Resistance of Clots Containing Fibrin, DNA, and Histones
- (2013) Colin Longstaff et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH
- (2013) M. Chitlur et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis
- (2013) Malgorzata Konieczynska et al. THROMBOSIS AND HAEMOSTASIS
- Venous Thromboembolism in Patients with Diabetes Mellitus
- (2012) Gregory Piazza et al. AMERICAN JOURNAL OF MEDICINE
- Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: A mass spectrometric and isotope labeling study
- (2012) Jan Svensson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fibrinogen and future cardiovascular disease in people with diabetes: Aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies
- (2012) Andre P Kengne et al. Diabetes & Vascular Disease Research
- Complement C3 is a novel plasma clot component with anti-fibrinolytic properties
- (2012) Joanna-Marie Howes et al. Diabetes & Vascular Disease Research
- Gender-Specific Alterations in Fibrin Structure Function in Type 2 Diabetes: Associations with Cardiometabolic and Vascular Markers
- (2012) Saad H. Alzahrani et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values
- (2012) M. PIETERS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
- (2012) B. ROCCA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
- (2012) Maciej Bochenek et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4
- (2011) F. Semeraro et al. BLOOD
- Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes
- (2011) Etheresia Pretorius et al. BLOOD COAGULATION & FIBRINOLYSIS
- Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease
- (2011) Leyla Ay et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation – The Hoorn Study
- (2011) Hanneke J.B.H. Beijers et al. THROMBOSIS RESEARCH
- Review article: Coagulation and fibrinolysis in diabetes
- (2010) SH Alzahrani et al. Diabetes & Vascular Disease Research
- Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus
- (2010) F. SANTILLI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay
- (2010) Armando Tripodi et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Extracellular DNA traps promote thrombosis
- (2010) T. A. Fuchs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System
- (2009) R.A. Ajjan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Is Diabetes Mellitus an Independent Risk Factor for Venous Thromboembolism?
- (2009) John A. Heit et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men
- (2009) Mirjam E. Meltzer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes: A BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy
- (2009) D. J. Schneider et al. DIABETES CARE
- Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease
- (2008) David S. Frankel et al. CIRCULATION
- Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
- (2008) A. Undas et al. DIABETES CARE
- Glycaemic control improves fibrin network characteristics in type 2 diabetes – A purified fibrinogen model
- (2008) Namukolo Covic et al. THROMBOSIS AND HAEMOSTASIS
- Thrombin generation, fibrin clot formation and hemostasis
- (2008) Alisa S. Wolberg et al. TRANSFUSION AND APHERESIS SCIENCE
- Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis
- (2008) Mirjam E Meltzer et al. PLOS MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started